Table 2
Inflammatory marker concentrations in serum from asymptomatic controls and two whiplash groups (recovered or milder symptoms at 3 months) measured at two time points.
| Acute Stage WAD | Chronic Stage WAD (3 months) | |||||
|---|---|---|---|---|---|---|
| Inflammatory Marker Concentration (median, IQR) | Asymptomatic controls | Recovered or Mild WAD 0-28% NDI | Moderate/severe WAD ≥ 30% NDI | Asymptomatic controls | Recovered or Mild WAD 0-28% NDI | Moderate/severe WAD ≥ 30% NDI |
| TNF-α (pg/ml) | 1.07 (0.56) | 1.33 (0.88)*^ | 1.13 (0.65) | 0.7 (0.13) | 1.4 (0.94)* ^ | 0.99 (0.7) |
| IL-1B (pg/ml) | 1.1 (0.9) | 1.2 (0.27) | 1.1 (0.7) | 1.1 (0.6) | 1.4 (0.8) | 1.5 (0.3) |
| CRP (mg/l) | 1.4 (0.25) | 2.4 (0.32)* | 2.5 (0.34)* | 1.0 (0.13) | 1.4 (0.37) | 3.9 (0.37)* ^ |
WAD: Whiplash Associated Disorders *denotes significant difference from control group at p<0.05
^denotes significant difference between WAD groups at p<0.05